RIVM and EFSA optimise new calculation model for mixture risk assessment Plant protection products (PPPs) are products used in agriculture to protect crops against, for example, fungi, insects and weeds.
Metabolic disorder ALD added to newborn blood spot screening Since 1 October, the metabolic disorder adrenoleukodystrophy (ALD) has been added to the Dutch newborn blood spot screening. From now on, the blood of newborn boys will also be tested for this disorder. ALD in boys can be treated if it is detected in time.
From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26 From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.
Can healthy gut microbes protect us against antibiotic-resistant bacteria? It is largely assumed within the scientific community that a healthy intestinal microbiome can provide resistance against the settling, growth and multiplication of antibiotic-resistant bacteria.
Antibiotic resistance no longer increasing but vigilance remains necessary After continuing to rise for many years, in 2013 the prevalence of resistance to antibiotics levelled out somewhat in both hospitals and primary care.
RIVM forecasting study: a healthier Netherlands with more people living with a chronic disease Dutch people are reaching an increasingly advanced age: in 2030, the life expectancy of men will be 82 years, and of women, 85.
International top conference about antibiotic resistance On 25 and 26 June, an international conference about resistance to antibiotics - an increasing worldwide problem - will take place in The Hague.